ClearPoint Neuro, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CLPT research report →
Companywww.clearpointneuro.com
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance.
- CEO
- Joseph Michael Burnett
- IPO
- 2012
- Employees
- 115
- HQ
- Solana Beach, CA, US
Price Chart
Valuation
- Market Cap
- $335.88M
- P/E
- -11.39
- P/S
- 8.27
- P/B
- 17.56
- EV/EBITDA
- -15.20
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 61.82%
- Op Margin
- -65.20%
- Net Margin
- -71.57%
- ROE
- -140.96%
- ROIC
- -31.46%
Growth & Income
- Revenue
- $36.97M · 17.78%
- Net Income
- $-25,540,000 · -35.03%
- EPS
- $-0.90 · -28.57%
- Op Income
- $-24,164,000
- FCF YoY
- -165.01%
Performance & Tape
- 52W High
- $30.10
- 52W Low
- $8.27
- 50D MA
- $10.59
- 200D MA
- $14.11
- Beta
- 1.29
- Avg Volume
- 763.82K
Get TickerSpark's AI analysis on CLPT
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 1, 26 | FLETCHER R JOHN | other | 1,270 |
| Apr 1, 26 | Girin Pascal E R | other | 755 |
| Apr 1, 26 | Richards Timothy T. | other | 442 |
| Mar 19, 26 | BURNETT JOSEPH | other | 20,942 |
| Mar 19, 26 | BURNETT JOSEPH | other | 20,942 |
| Mar 12, 26 | D'Alessandro Danilo | other | 32,627 |
| Mar 12, 26 | D'Alessandro Danilo | other | 16,601 |
| Mar 12, 26 | D'Alessandro Danilo | other | 32,627 |
| Mar 12, 26 | BURNETT JOSEPH | other | 84,829 |
| Mar 12, 26 | BURNETT JOSEPH | other | 43,161 |
Our CLPT Coverage
We haven't published any research on CLPT yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CLPT Report →